Disc Medicine, Inc.IRONNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +23.11% | +27.04% | +34.32% | +36.55% | +17.51% |
| Weighted Average Shares Diluted Growth | +23.11% | +27.05% | +34.32% | +36.55% | +17.51% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +31.51% | +34.99% | +100.25% | +30.35% | +27.33% |
| Book Value per Share Growth | +5.89% | +1.17% | +45.42% | -7.99% | +4.27% |
| Debt Growth | -8.78% | +1327.89% | +1412.44% | +1583.29% | +1632.49% |
| R&D Expense Growth | +71.20% | +9.85% | +17.12% | +97.23% | +103.55% |
| SG&A Expenses Growth | +80.02% | +36.42% | +57.04% | +104.85% | +112.48% |